CCND1 and glioblastoma: In line with this, a preliminary clinical study demonstrated co-localisation between Beclin-1 and Cyclin D1 in glioblastoma patient’s primary and recurrent tumours treated with temozolomide and radiotherapy it was suggested that autophagy was removing Cyclin D1 (Luigi et al., 2016) which is an important regulator of cell cycle arrest.